AIDS DRUG ASSISTANCE PROTOCOL
FUND
  ADAP Main Page

New and Noteworthy
 Prioritization Guidelines
 Funding Needs/Budgets
 Ethical Challenges   
Position Papers 
General Reports
 Conference Reports
 State Formularies
 State Challenges
NASTAD Reports
 Case Management

 

 Program Analyses 
Medicare and ADAP
Links  
Videos
Journal of Timely and Appropriate Care





 








 
 
US AIDS Drug Access Main Page    
LAST UPDATE  August 13, 2011
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
New and Noteworthy
     

August 2011
 
ADAP Funding Crisis on CN2
 

ADAP Funding/Budgets
       
General Reports
       
     Internet Document
 
 
FULL-TEXT PDF DOCUMENT
NASTAD ADAP Watch
NASTAD  June 04, 2009
 Internet Document

FULL-TEXT ARTICLE
 The Very Model of a Modern Major Modeler: An Interview with Kit N. Simpson, DrPH
 on her New Cost-of Care Model for HIV Care
 Simpson KN, Hawes J   
ADAP Fund/MedAdvocates
January 16, 2008
 Internet Document
 
 

    Journal Papers, Abstracts, and Commentaries
 
 
The Impact of the AIDS Drug Assistance Program (ADAP) on Use of Highly Active Antiretroviral and
Antihypertensive Therapy among HIV-Infected Women.
Yi T, Cocohoba J, Cohen M, et alJ
Acquir Immune Defic Syndr. 2010 Dec 25
 Abstract

Improving Outcomes in State AIDS Drug Assistance Programs.
Linas BP, Losina E, Rockwell A, et al 
J Acquir Immune Defic Syndr. 2009 Jun 25
 Abstract

AIDS Drug Assistance Programs in the Era of Routine HIV Testing.
Bassett IV, Farel C, Szmuilowicz ED, Walensky RP.
Clin Infect Dis. 2008 Jul 21.
 Abstract
 
A WEEK-IN-REVIEW FEATURED REPORT
Market power and state costs of HIV/AIDS drugs.
Leibowitz AA, Sood N.
Int J Health Care Finance Econ. 2007 May 5;
 Abstract
 
Optimizing resource allocation in United States AIDS drug assistance programs.
Linas BP, Zheng H, Losina E. et al
Clin Infect Dis. 2006 Nov 15;43(10):1357-64
 Abstract
 
The relationship between HAART use and employment for HIV-positive individuals:
an empirical analysis and policy outlook.
Bernell SL, Shinogle JA.  
Health Policy. 2005 Feb;71(2):255-64.
 Abstract
 
FULL-TEXT ARTICLE
 Advocate Profiles: William E. Arnold
Hinchey M  Darwell  W
JTAC January 2004
Paper

AIDS Drug Assistance Programs: highlighting inequities in human immunodeficiency
virus-infection health care in the United States.
Walensky RP, Paltiel AD, Freedberg KA.
Clin Infect Dis. 2002 Sep 1;35(5):606-10.
 Abstract
 
State AIDS Drug Assistance Programs: equity and efficiency in an era of rapidly
changing treatment standards.
Johri M, David Paltiel A, et al
Med Care. 2002 May;40(5):429-4
Abstract

'The AIDS drug assistance programs and coverage of HIV-related medications.
Smith SR, Buchanan RJ.
Ann Pharmacother 2001 Feb;35(2):155-66
Abstract
 

  
      Conference Reports, Abstracts, and Commentaries
 
  Access to HIV treatment, care and prevention from persons living with HIV/AIDS:
results of a comprehensive survey of ADAP recipients
 L.R. Frank, J. Folby, J. Pease
 (XVII International AIDS Conference)
 Abstract

     Internet Documents

 

Medical Advocates
Stavudine (Zerit)
 
Main Page
 
New and Noteworthy